| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/15/2011 | CN101524409B Chinese medicine composition used for improving the level of serum testosterone |
| 06/15/2011 | CN101472574B Agent for increasing testosterone level |
| 06/14/2011 | US7960367 Pregnane steroids and their use in the treatment of CNS disorders |
| 06/14/2011 | US7960341 Methods and compositions for treating polycystic ovary syndrome |
| 06/14/2011 | CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2338419C Pulmonary delivery of active agents |
| 06/09/2011 | WO2011069038A2 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | US20110136915 Rapid dissolution formulation of a calcium receptor-active compound |
| 06/09/2011 | US20110136821 Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase Type 1 |
| 06/09/2011 | US20110136815 Solid oral film dosage forms and methods for making same |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135719 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 06/09/2011 | US20110135651 Method and composition for enhancing hematopoietic stem cell mobilization |
| 06/09/2011 | US20110135614 Modified growth hormone |
| 06/09/2011 | CA2782691A1 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102086197A Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 06/08/2011 | CN102085269A Traditional Chinese medicine composition for treating polycystic ovary syndrome (PCOS) and application thereof |
| 06/08/2011 | CN101822662B Application of 9,10-dioxystearic acid (DHSA) in preparing medicaments for preventing and treating diabetes |
| 06/08/2011 | CN101212972B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 06/08/2011 | CN101068764B Estrogen receptor modulators |
| 06/07/2011 | US7956091 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 06/07/2011 | CA2628607C Androgen synthesis inhibitors |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2473068C Starch derivatives, starch active-substance conjugates, method for their preparation and their use as drugs |
| 06/07/2011 | CA2388857C Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same |
| 06/03/2011 | WO2011064769A1 Methods and pharmaceutical compositions for the treatment of hot flashes |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/02/2011 | US20110130447 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130330 Topical Drug Delivery Using Phosphatidylcholine |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129535 Transdermal testosterone device and delivery |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | CN102083780A Diglycidic ether derivative therapeutics and methods for their use |
| 06/01/2011 | CN102083458A Super fast-acting insulin compositions |
| 06/01/2011 | CN102079821A Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
| 06/01/2011 | CN102078500A Chinese traditional medicine for treating hyperthyroidism |
| 06/01/2011 | CN102078458A Chinese patent medicine for treating cryptorrhea |
| 06/01/2011 | CN102078394A Aconite extract-containing medicinal composition, preparation method and application thereof |
| 06/01/2011 | CN101721376B Calcitonin sustained release microsphere composition and preparation method thereof |
| 06/01/2011 | CN101647827B Method for preparing female silkworm moth powder with high estradiol content |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | CA2623477C Compositions and method for treating pediatric hypogonadism |
| 05/31/2011 | CA2603866C Androgen modulators |
| 05/31/2011 | CA2521182C Composition for improving cognition and memory |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/26/2011 | WO2010032006A8 Treatment of adrenal insufficiency |
| 05/26/2011 | US20110124725 Treatment for Meibomian Gland Dysfunction or Obstruction |
| 05/26/2011 | US20110124699 Method for treating nervous system disorders and conditions |
| 05/26/2011 | US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 05/26/2011 | US20110124617 Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent |
| 05/26/2011 | US20110124611 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/26/2011 | US20110124562 Apoaequorin-containing compositions and methods of using same |
| 05/26/2011 | US20110123608 Pharmaceutical formulation |
| 05/26/2011 | US20110123513 Alkaline phosphatase to reduce or prevent weight gain |
| 05/25/2011 | EP2324059A1 Anti-pamp therapeutic antibodies |
| 05/25/2011 | EP2324058A1 Biological applications of steroid binding domains |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity |
| 05/25/2011 | CN102070541A Letrozole I-type crystal and preparation method thereof |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068429A Application of fadrozole in inducing transformation of differentiated ovary of tilapia mossambica into functional testis and induction method thereof |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/24/2011 | US7947726 Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof |
| 05/24/2011 | US7947697 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist |
| 05/24/2011 | CA2468719C Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/24/2011 | CA2463626C Piperidine- and piperazineacetamines as 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/19/2011 | WO2011060019A1 Androgen receptor modulator and uses thereof |
| 05/19/2011 | WO2011059839A1 Bicyclic pyridines and analogs as sirtuin modulators |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011057382A1 Spirocyclic piperidine derivatives useful as renin inhibitors |
| 05/19/2011 | WO2011004260A3 Composition for the treatment of benign prostate hyperplasia |
| 05/19/2011 | US20110118353 Method of hormone suppression in humans |
| 05/19/2011 | US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 |
| 05/19/2011 | US20110118227 Methods for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome |
| 05/19/2011 | US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them |
| 05/19/2011 | US20110118183 N-glycosylated human growth hormone with prolonged circulatory half-life |
| 05/19/2011 | US20110117226 Uses of conglutin-gamma |
| 05/19/2011 | US20110117162 Isolated Renal Cells and Uses Thereof |
| 05/19/2011 | CA2780732A1 Androgen receptor modulator and uses thereof |
| 05/19/2011 | CA2779303A1 Bicyclic pyridines and analogs as sirtuin modulators |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322551A2 Compositions comprising Anti-IGF-1R Antibodies and Methods for their Production |
| 05/18/2011 | EP2322550A1 Compositions comprising anti-IGF-1R Antibodies and Methods for obtaining said Antibodies |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |